Science Saturday

Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides ...

Athletes with a genetic heart disease are often disqualified from participating in competitive sports because of the perceived risk of sudden cardiac arrest. While the clinicians' intent may ...

Could prescribing specific nutrients, grains, fruits and vegetables tailored to a person's DNA and other biological characteristics help improve their health? Precision nutrition took center stage ...

Mayo Clinic researchers found a noncellular substance suggested improvement in restoring muscle function and bladder control in preclinical models. The teams of Atta Behfar, M.D., Ph.D. and Emanuel ...

Mayo Clinic researchers replicated chronic dry mouth from radiation damage in preclinical models, laying the foundation for stem cell research to regenerate salivary tissue after ...

Mayo Clinic researchers and collaborators have identified key clinical findings that can help clinicians recognize patients with potentially treatable causes of rapidly progressive dementia, who ...

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome ...

Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise ...

In a new study, Mayo Clinic researchers identified substantial health disparities in rural versus urban areas in diabetes-related deaths, with other disparities based on gender. Using nationwide ...

In a new study published in Nature Medicine, Mayo Clinic and several research collaborators from across the U.S., describe a successful new artificial intelligence, or AI, -enabled ...

The tools of molecular medicine are designed to work in remote regions of inner space — places in the body that aren't easy to see ...

Advancing cellular discoveries from clinical trials to commercial therapy is a cornerstone of Mayo Clinic's strategic emphasis on biomanufacturing. The long-term vision is to provide new ...